• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺增生症的治疗选择

Therapeutic options in the treatment of benign prostatic hyperplasia.

作者信息

Sandhu Jaspreet S

机构信息

Department of Surgery Division of Urology Memorial Sloan-Kettering Cancer Center New York, NY 10065 USA.

出版信息

Patient Prefer Adherence. 2009 Nov 3;3:213-23. doi: 10.2147/ppa.s4028.

DOI:10.2147/ppa.s4028
PMID:19936164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2778433/
Abstract

Current theraputic options for the treatment of symptomatic benign prostatic hyperplasia (BPH) are reviewed. Therapeutic options for mild lower urinary tract symptoms (LUTS), as defined by the American Urological Association, are generally treated medically. Moderate to severe LUTS can be treated medically or with surgical therapy. Current medical and surgical treatments for LUTS secondary to BPH are reviewed and evolving treatments are explored.

摘要

本文综述了目前治疗有症状良性前列腺增生(BPH)的治疗选择。美国泌尿外科学会定义的轻度下尿路症状(LUTS)的治疗选择通常采用药物治疗。中度至重度LUTS可采用药物治疗或手术治疗。本文综述了目前针对BPH继发LUTS的药物和手术治疗方法,并探讨了正在发展的治疗方法。

相似文献

1
Therapeutic options in the treatment of benign prostatic hyperplasia.良性前列腺增生症的治疗选择
Patient Prefer Adherence. 2009 Nov 3;3:213-23. doi: 10.2147/ppa.s4028.
2
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.前列腺素途径在接受药物治疗失败的良性前列腺增生症伴下尿路症状患者中被激活。
Prostate. 2021 Sep;81(13):944-955. doi: 10.1002/pros.24190. Epub 2021 Jul 20.
3
[Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].[良性前列腺增生相关下尿路症状的初始评估、随访及治疗:法国泌尿外科学会下尿路症状委员会指南]
Prog Urol. 2012 Dec;22(16):977-88. doi: 10.1016/j.purol.2012.10.001. Epub 2012 Nov 6.
4
Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.良性前列腺增生症下尿路症状的治疗及其对性功能的影响。
Clin Ther. 2006 Jan;28(1):13-25. doi: 10.1016/j.clinthera.2006.01.004.
5
Benign prostatic hyperplasia: from bench to clinic.良性前列腺增生:从实验室到临床
Korean J Urol. 2012 Mar;53(3):139-48. doi: 10.4111/kju.2012.53.3.139. Epub 2012 Mar 19.
6
Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.前列腺体积是否可预测有轻度至无当前症状的男性中出现下尿路症状的发展?来自 REDUCE 试验的结果。
Eur Urol. 2016 May;69(5):885-91. doi: 10.1016/j.eururo.2015.12.002. Epub 2015 Dec 24.
7
Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial.前列腺动脉栓塞术与经尿道前列腺切除术治疗良性前列腺增生:一项非劣效性临床试验方案
Res Rep Urol. 2018 Feb 13;10:17-22. doi: 10.2147/RRU.S139086. eCollection 2018.
8
[Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].[全科医生管理良性前列腺增生相关下尿路症状指南]
Prog Urol. 2015 Jun;25(7):404-12. doi: 10.1016/j.purol.2015.02.008. Epub 2015 Apr 2.
9
Current consensus and controversy on the treatment of male lower urinary tract symptoms/benign prostatic hyperplasia.男性下尿路症状/良性前列腺增生治疗的当前共识与争议
Tzu Chi Med J. 2017 Jan-Mar;29(1):1-5. doi: 10.4103/tcmj.tcmj_2_17.
10
Holter Monitoring (24-Hour ECG) Parameter Dynamics in Patients with Ischemic Heart Disease and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.动态心电图(24 小时心电图)监测在缺血性心脏病合并良性前列腺增生症下尿路症状患者中的参数变化
Adv Ther. 2019 Aug;36(8):2072-2085. doi: 10.1007/s12325-019-00977-8. Epub 2019 May 30.

引用本文的文献

1
Cucurbitacin B Inhibits the Proliferation of WPMY-1 Cells and HPRF Cells via the p53/MDM2 Axis.葫芦素 B 通过 p53/MDM2 轴抑制 WPMY-1 细胞和 HPRF 细胞的增殖。
Int J Mol Sci. 2024 Aug 28;25(17):9333. doi: 10.3390/ijms25179333.
2
Successful treatment of complicated benign prostatic hyperplasia in a diabetic patient with water vapor thermal therapy and urethral stenting.水蒸气热疗联合尿道支架置入术成功治疗糖尿病患者的复杂性良性前列腺增生症
Urol Case Rep. 2019 May 22;26:100921. doi: 10.1016/j.eucr.2019.100921. eCollection 2019 Sep.
3
The diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia by primary care family physicians in Portugal.葡萄牙基层家庭医生对良性前列腺增生所致下尿路症状的诊断与治疗
Clin Drug Investig. 2015 Feb;35 Suppl 1:19-27. doi: 10.1007/s40261-014-0256-4.

本文引用的文献

1
Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results.肉毒杆菌毒素缓解良性前列腺增生所致下尿路症状的早期及长期效果
Urology. 2009 Jan;73(1):90-4. doi: 10.1016/j.urology.2008.08.475. Epub 2008 Nov 8.
2
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.托特罗定缓释制剂联合或不联合坦索罗辛对下尿路症状男性尿急指标及患者报告结局的影响。
J Urol. 2008 Sep;180(3):1034-41. doi: 10.1016/j.juro.2008.05.050. Epub 2008 Jul 17.
3
Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.在患有包括膀胱过度活动症症状在内的下尿路症状的男性中,托特罗定缓释剂联合或不联合坦索罗辛:前列腺大小的影响
Eur Urol. 2009 Feb;55(2):472-9. doi: 10.1016/j.eururo.2008.06.032. Epub 2008 Jun 17.
4
Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.良性前列腺增生手术治疗的实践模式:微创技术的显著增加
J Urol. 2008 Jul;180(1):241-5; discussion 245. doi: 10.1016/j.juro.2008.03.039. Epub 2008 May 21.
5
Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients.经尿道前列腺切除术的发病率、死亡率及早期预后:对10654例患者的前瞻性多中心评估
J Urol. 2008 Jul;180(1):246-9. doi: 10.1016/j.juro.2008.03.058. Epub 2008 May 21.
6
A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.一项随机、安慰剂对照研究,旨在评估每日两次服用伐地那非治疗良性前列腺增生继发下尿路症状的疗效。
Eur Urol. 2008 Jun;53(6):1236-44. doi: 10.1016/j.eururo.2008.01.075. Epub 2008 Feb 4.
7
Microwave thermotherapy for benign prostatic hyperplasia.微波热疗治疗良性前列腺增生症。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD004135. doi: 10.1002/14651858.CD004135.pub2.
8
Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial.钬激光前列腺剜除术与开放性前列腺切除术治疗100克以上前列腺的比较:一项随机临床试验的5年随访结果
Eur Urol. 2008 Jan;53(1):160-6. doi: 10.1016/j.eururo.2007.08.036. Epub 2007 Aug 28.
9
Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve.钬激光前列腺剜除术(HoLEP):长期结果、再次手术率及学习曲线的可能影响
Eur Urol. 2007 Nov;52(5):1465-71. doi: 10.1016/j.eururo.2007.04.074. Epub 2007 May 4.
10
A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system.一项使用经尿道盐水切除(TURIS)系统比较单极和双极经尿道前列腺切除术的前瞻性随机研究。
Eur Urol. 2007 Aug;52(2):517-22. doi: 10.1016/j.eururo.2007.03.038. Epub 2007 Mar 28.